ITRM Market Cap History



Below is a table of the ITRM market cap history going back to 5/25/2018:

Date ITRM Market Cap
5/25/2018168.88M
7/31/2018131.54M
10/31/201886.30M
2/28/201981.46M
4/30/2019116.39M
7/31/201994.48M
9/18/2018118.38M
10/31/201940.15M
2/29/202035.69M
4/30/202052.04M
7/31/202022.09M
10/31/202020.40M
2/28/2021289.42M
4/30/2021220.34M
7/31/2021142.38M
10/31/202197.60M
2/28/202272.93M
4/30/202246.57M
7/31/202240.37M
10/31/202220.67M
4/30/202315.14M
7/31/202313.82M
10/31/20238.53M
2/29/202420.37M

Also see: ITRM Shares Outstanding History
and ITRM YTD Return
ITRM Historical Market Cap:
-30.69% CAGR
ITRM Historical Market Cap: +-30.69% CAGR

Mouse over chart for data details
5/25/2018 ...2/29/2024
Iterum Therapeutics is a clinical-stage pharmaceutical company focused on developing and commercializing sulopenem oral to be an oral penem available in the U.S. and an oral and intravenous (IV) branded penem available globally. The objective of Co.'s sulopenem program is to deliver to patients an oral and IV formulation of sulopenem approved in the U.S. and Europe for the treatment of infections due to resistant gram-negative pathogens. Co. has also developed sulopenem in an oral tablet formulation, sulopenem etzadroxil-probenecid. We show 24 historical shares outstanding datapoints in our ITRM shares outstanding history coverage, used to compute ITRM market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ITRM market cap history over the course of time is important for investors interested in comparing ITRM's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ITRM versus a peer is one thing; comparing ITRM market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ITRM can fluctuate over the course of history. With this page we aim to empower investors researching ITRM by allowing them to research the ITRM market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ITRM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Iterum Therapeutics (ITRM) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

IUS Market Cap History
IVA Market Cap History
IVAN Market Cap History
IVCA Market Cap History
IVCB Market Cap History
IVCP Market Cap History
IXAQ Market Cap History
IXSE Market Cap History
IYLD Market Cap History
IZM Market Cap History
More Miscellaneous companies »

 

ITRM Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.